Showing results (1-10 of 609) with videos related to
Sort By:
Pageof 61
The American Journal of Medicine|January 1, 1985
Infectious peritonitis in patients receiving intraperitoneal chemotherapyR A Kaplan, M Markman, W E Lucas, et al.Cancer|July 1, 1986
Cisplatin administered by the intracavitary route as treatment for malignant mesotheliomaM Markman, S Cleary, C Pfeifle, et al.American Journal of Obstetrics and Gynecology|June 15, 1985
Intraperitoneal chemotherapy for advanced ovarian cancerW E Lucas, M Markman, S B HowellMedical and Pediatric Oncology|January 1, 1984
Anaphylactic reaction to cytarabine: in vitro evidence that the response is immunoglobulin E mediatedM Markman, S B Howell, M King, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavityM Markman, S Cleary, W E Lucas, et al.Cancer Drug Delivery|January 1, 1985
The intraoperative intraperitoneal administration of cisplatin: a case reportM Markman, R Weiss, S B Howell, et al.Surgery, Gynecology & Obstetrics|May 1, 1986
Complications of extensive adhesion formation after intraperitoneal chemotherapyM Markman, S Cleary, S B Howell, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1984
Totally implantable system for peritoneal accessC E Pfeifle, S B Howell, M Markman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1984
Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavityM Markman, S B Howell, W E Lucas, et al.Cancer Drug Delivery|January 1, 1985
Daily intraperitoneal administration of cytarabine in a patient with peritoneal mesotheliomaM Markman, S B HowellPageof 61